Comparison of pharmacokinetics and safety of reference bevacizumab (EU and US bevacizumab) and its biosimilar candidate CT-P16J. G. Shin,J. L. Ghim,S. H. Cho,M. S. Nam, S. Han, S. Yu,T. Park,S. Kim,J. BaeEUROPEAN JOURNAL OF CANCER(2018)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要